BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Oral solithromycin: Phase II started

Cempra began a double-blind, placebo-controlled Phase II trial to compare oral solithromycin vs. levofloxacin in 150 patients. Patients will receive 200 mg solithromycin administered 4 times on day 1 and twice daily on...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >